177 related articles for article (PubMed ID: 18580449)
41. Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau disease.
Albanyan S; Giles RH; Gimeno EM; Silver J; Murphy J; Faghfoury H; Morel CF; Machado J; Kim RH
Eur J Med Genet; 2019 Mar; 62(3):177-181. PubMed ID: 30006056
[TBL] [Abstract][Full Text] [Related]
42. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
43. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
44. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
[TBL] [Abstract][Full Text] [Related]
45. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
[TBL] [Abstract][Full Text] [Related]
46. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K
Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279
[TBL] [Abstract][Full Text] [Related]
47. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
[TBL] [Abstract][Full Text] [Related]
48. Germline VHL gene variant in patients with von Hippel-Lindau disease does not predict renal tumor growth.
Farhadi F; Nikpanah M; Li X; Symons R; Pourmorteza A; Merino MJ; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Oct; 43(10):2743-2749. PubMed ID: 29525880
[TBL] [Abstract][Full Text] [Related]
49. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
50. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
51. Difficult diagnosis of atypical cystic pancreatic lesions in von Hippel-Lindau disease.
Neuzillet C; Vullierme MP; Couvelard A; Sauvanet A; Levy P; Richard S; Ruszniewski P; Hammel P
J Comput Assist Tomogr; 2010 Jan; 34(1):140-5. PubMed ID: 20118737
[TBL] [Abstract][Full Text] [Related]
52. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
53. Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.
Gaal J; van Nederveen FH; Erlic Z; Korpershoek E; Oldenburg R; Boedeker CC; Kontny U; Neumann HP; Dinjens WN; de Krijger RR
J Clin Endocrinol Metab; 2009 Nov; 94(11):4367-71. PubMed ID: 19808854
[TBL] [Abstract][Full Text] [Related]
54. Germline mutations in the von Hippel-Lindau gene in Italian patients.
Ciotti P; Garuti A; Gulli R; Ballestrero A; Bellone E; Mandich P
Eur J Med Genet; 2009; 52(5):311-4. PubMed ID: 19464396
[TBL] [Abstract][Full Text] [Related]
55. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
56. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
[TBL] [Abstract][Full Text] [Related]
57. Single case of renal cell carcinoma and endocrine pancreatic head cancer occurring with von Hippel-Lindau disease.
Osawa A; Sumiyama Y; Watanabe M; Tanaka H; Asai K; Enomoto T; Matsukiyo H; Kanai R; Takeuchi Y; Oharazeki T
J Hepatobiliary Pancreat Surg; 2006; 13(2):174-80. PubMed ID: 16547682
[TBL] [Abstract][Full Text] [Related]
58. A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.
Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H
J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291
[TBL] [Abstract][Full Text] [Related]
59. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
60. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
